Home > Drug misuse prevention review.

Advisory Council on the Misuse of Drugs. (2022) Drug misuse prevention review. London: Advisory Council on the Misuse of Drugs.

PDF (Drug misuse prevention review.)

The recommendations from the ACMD, directed at the cross-government Joint Combating Drugs Unit, Department for Health and Social Care, and Department for Education, are that the government should: 

  • reflect in its policies and guidance the drug prevention approaches recommended by the United Nations Office on Drugs and Crime, the World Health Organization and the National Institute for Health and Care Excellence 
  • not pursue drug prevention activities that the ACMD has found to be ineffective, for example approaches that cause fear in the target groups or stand-alone mass media campaigns - only activities that have been properly resourced and are based on peer reviewed, evaluative research should be used 
  • fund further research to improve understanding of adult vulnerability to drug use, with resources to support this identified within the innovation fund announced with the Drugs Strategy 
  • in consultation with professional bodies and prevention experts, invest in and mandate workforce training and resources to ensure that the professionals dealing with vulnerable drug users are equipped to respond appropriately 
  • not focus solely on vulnerable groups as this will limit the reach of prevention activities and contribute the stigmatisation and discrimination; instead, the government should acknowledge the varied nature of vulnerability and consider the impact of social environments on overall well-being

See also, December 15 2023 - UK Government response to the ACMD's drug misuse prevention review

Item Type
Publication Type
International, Report
Drug Type
All substances
Intervention Type
May 2022
54 p.
Advisory Council on the Misuse of Drugs
Corporate Creators
Advisory Council on the Misuse of Drugs
Place of Publication

Repository Staff Only: item control page